| UniProt ID | SC6A3_HUMAN | |
|---|---|---|
| UniProt AC | Q01959 | |
| Protein Name | Sodium-dependent dopamine transporter | |
| Gene Name | SLC6A3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 620 | |
| Subcellular Localization |
Cell membrane Multi-pass membrane protein . |
|
| Protein Description | Amine transporter. Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals.. | |
| Protein Sequence | MSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNPRQSPVEAQDRETWGKKIDFLLSVIGFAVDLANVWRFPYLCYKNGGGAFLVPYLLFMVIAGMPLFYMELALGQFNREGAAGVWKICPILKGVGFTVILISLYVGFFYNVIIAWALHYLFSSFTTELPWIHCNNSWNSPNCSDAHPGDSSGDSSGLNDTFGTTPAAEYFERGVLHLHQSHGIDDLGPPRWQLTACLVLVIVLLYFSLWKGVKTSGKVVWITATMPYVVLTALLLRGVTLPGAIDGIRAYLSVDFYRLCEASVWIDAATQVCFSLGVGFGVLIAFSSYNKFTNNCYRDAIVTTSINSLTSFSSGFVVFSFLGYMAQKHSVPIGDVAKDGPGLIFIIYPEAIATLPLSSAWAVVFFIMLLTLGIDSAMGGMESVITGLIDEFQLLHRHRELFTLFIVLATFLLSLFCVTNGGIYVFTLLDHFAAGTSILFGVLIEAIGVAWFYGVGQFSDDIQQMTGQRPSLYWRLCWKLVSPCFLLFVVVVSIVTFRPPHYGAYIFPDWANALGWVIATSSMAMVPIYAAYKFCSLPGSFREKLAYAIAPEKDRELVDRGEVRQFTLRHWLKV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSKSKCSVG ------CCCCCCCCC | 45.71 | 16908408 | |
| 4 | Phosphorylation | ----MSKSKCSVGLM ----CCCCCCCCCCC | 31.42 | 16908408 | |
| 5 | Ubiquitination | ---MSKSKCSVGLMS ---CCCCCCCCCCCC | 33.98 | - | |
| 7 | Phosphorylation | -MSKSKCSVGLMSSV -CCCCCCCCCCCCCC | 23.98 | 22817900 | |
| 12 | Phosphorylation | KCSVGLMSSVVAPAK CCCCCCCCCCEECCC | 25.64 | 22817900 | |
| 13 | Phosphorylation | CSVGLMSSVVAPAKE CCCCCCCCCEECCCC | 13.47 | 22817900 | |
| 48 | Phosphorylation | QLTSSTLTNPRQSPV ECEECCCCCCCCCCC | 43.17 | - | |
| 53 | Phosphorylation | TLTNPRQSPVEAQDR CCCCCCCCCCCCCCH | 31.99 | 25332170 | |
| 62 | Phosphorylation | VEAQDRETWGKKIDF CCCCCHHHHHHHHHH | 40.17 | 22817900 | |
| 181 | N-linked_Glycosylation | ELPWIHCNNSWNSPN CCCEEECCCCCCCCC | 31.26 | 12429746 | |
| 181 | N-linked_Glycosylation | ELPWIHCNNSWNSPN CCCEEECCCCCCCCC | 31.26 | 12429746 | |
| 188 | N-linked_Glycosylation | NNSWNSPNCSDAHPG CCCCCCCCCCCCCCC | 37.43 | 12429746 | |
| 188 | N-linked_Glycosylation | NNSWNSPNCSDAHPG CCCCCCCCCCCCCCC | 37.43 | 12429746 | |
| 205 | N-linked_Glycosylation | SGDSSGLNDTFGTTP CCCCCCCCCCCCCCC | 50.21 | 12429746 | |
| 205 | N-linked_Glycosylation | SGDSSGLNDTFGTTP CCCCCCCCCCCCCCC | 50.21 | 12429746 | |
| 261 | Phosphorylation | SLWKGVKTSGKVVWI HHHCCCCCCCCEEEE | 40.06 | 16740633 | |
| 262 | Phosphorylation | LWKGVKTSGKVVWIT HHCCCCCCCCEEEEE | 30.79 | 22210691 | |
| 269 | Phosphorylation | SGKVVWITATMPYVV CCCEEEEECCHHHHH | 10.60 | 22210691 | |
| 271 | Phosphorylation | KVVWITATMPYVVLT CEEEEECCHHHHHHH | 15.27 | 22210691 | |
| 278 | Phosphorylation | TMPYVVLTALLLRGV CHHHHHHHHHHHCCC | 12.03 | - | |
| 286 | Phosphorylation | ALLLRGVTLPGAIDG HHHHCCCCCCCCHHH | 30.02 | - | |
| 593 | Phosphorylation | SFREKLAYAIAPEKD CHHHHHHHHHCCCCC | 14.69 | - | |
| 613 | Phosphorylation | RGEVRQFTLRHWLKV HHHHHHHHHHHHHCC | 17.97 | 24719451 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 2 | S | Phosphorylation | Kinase | CAMK2A | P11798 | PSP |
| 4 | S | Phosphorylation | Kinase | CAMK2A | P11798 | PSP |
| 7 | S | Phosphorylation | Kinase | CAMK2A | P11798 | PSP |
| 7 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
| 12 | S | Phosphorylation | Kinase | CAMK2A | P11798 | PSP |
| 12 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
| 13 | S | Phosphorylation | Kinase | CAMK2A | P11798 | PSP |
| - | K | Ubiquitination | E3 ubiquitin ligase | NEDD4 | P46934 | PMID:20051513 |
| - | K | Ubiquitination | E3 ubiquitin ligase | NEDD4L | Q96PU5 | PMID:16885233 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SC6A3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SC6A3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SYUA_HUMAN | SNCA | physical | 12672538 | |
| TGFI1_HUMAN | TGFB1I1 | physical | 12177201 | |
| TGFI1_MOUSE | Tgfb1i1 | physical | 12177201 | |
| PICK1_HUMAN | PICK1 | physical | 11343649 | |
| SYUA_HUMAN | SNCA | physical | 11292651 | |
| NEDD4_HUMAN | NEDD4 | physical | 16885233 | |
| EPS15_HUMAN | EPS15 | physical | 16885233 | |
| EPN1_HUMAN | EPN1 | physical | 16885233 | |
| STX1A_HUMAN | STX1A | physical | 18617632 | |
| SYUA_HUMAN | SNCA | physical | 14550771 | |
| SYUA_HUMAN | SNCA | physical | 14756560 | |
| SYUA_HUMAN | SNCA | physical | 16216085 | |
| TBA1B_HUMAN | TUBA1B | physical | 16216085 | |
| TBB1_HUMAN | TUBB1 | physical | 16216085 | |
| STX1A_HUMAN | STX1A | physical | 25774383 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 613135 | Parkinsonism-dystonia infantile (PKDYS) | |||||
| Kegg Drug | ||||||
| D00110 | Cocaine (USP); Cocaine (TN) | |||||
| D00367 | Mazindol (JAN/USP/INN); Sanorex (TN) | |||||
| D02074 | Amphetamine sulfate (USP); Benzedrine (TN) | |||||
| D02078 | Dextroamphetamine sulfate (USP); Dexedrine (TN); Dextrostat (TN) | |||||
| D02182 | Cocaine hydrochloride (JP16/USP); Cocaine hydrochloride (TN) | |||||
| D02242 | Methamphetamine hydrochloride (JP16/USP); Desoxyn (TN) | |||||
| D02571 | Sibutramine hydrochloride hydrate (JAN); Sibutramine hydrochloride (USAN); Sibutramine hydrochloride | |||||
| D02897 | Amfonelic acid (USAN); Acidum amfonelicum (INN) | |||||
| D03110 | Bicifadine hydrochloride (USAN) | |||||
| D03713 | Dexfenfluramine hydrochloride (USAN); d-Fenfluramine hydrochloride; Redux (TN) | |||||
| D03740 | Dextroamphetamine (USAN); Dexamfetamine (INN) | |||||
| D04747 | Lisdexamfetamine dimesylate (USAN); Vyvanse (TN); Elvanse (TN) | |||||
| D05663 | Pyrovalerone hydrochloride (USAN) | |||||
| D07445 | Amfetamine (INN); Amphetamine; Amfetamin (TN) | |||||
| D07805 | Dexfenfluramine (INN) | |||||
| D08130 | Lisdexamfetamine (INN) | |||||
| D08187 | Metamfetamine (INN); Methamphetamine | |||||
| D08513 | Sibutramine (INN); Butramin (TN) | |||||
| D10014 | Ioflupane I 123 (USAN); Datscan (TN) | |||||
| D10088 | Amitifadine (USAN) | |||||
| D10089 | Amitifadine hydrochloride (USAN) | |||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...